Browsing Over 3689 Presentations

Sort By
Defining optimal response in myeloma Multidisciplinary session

Imaging (ID 37)

Lecture Time
11:05 - 11:20
Speakers
  • Sally F. Barrington (London, United Kingdom)
Session Name
Defining optimal response in myeloma
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
10:30 - 11:30
Defining optimal response in myeloma Multidisciplinary session

Haematology and immunophenotyping (ID 38)

Lecture Time
10:35 - 10:50
Speakers
  • Jesus F. San-Miguel (Pamplona, Spain)
Session Name
Defining optimal response in myeloma
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
10:30 - 11:30
DNA damage response modification as a therapeutic strategy in head and neck cancer Special symposium

Windows of opportunity studies and basket trials on DNA damage modifiers (ID 39)

Lecture Time
09:35 - 09:55
Speakers
  • Irene Brana (Barcelona, Spain)
Session Name
DNA damage response modification as a therapeutic strategy in head and neck cancer
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
DNA damage response modification as a therapeutic strategy in head and neck cancer Special symposium

Synthetic lethal approaches to enhancing chemotherapy and radiotherapy (ID 40)

Lecture Time
08:35 - 08:55
Speakers
  • Eric Deutsch (Villejuif, France)
Session Name
DNA damage response modification as a therapeutic strategy in head and neck cancer
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
DNA damage response modification as a therapeutic strategy in head and neck cancer Special symposium

Clinical trials of ATR inhibition (ID 41)

Lecture Time
08:55 - 09:15
Speakers
  • Magnus Dillon (London, United Kingdom)
Session Name
DNA damage response modification as a therapeutic strategy in head and neck cancer
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
DNA damage response modification as a therapeutic strategy in head and neck cancer Special symposium

Nucleic acid sensing as a driver of tumour immunogenicity (ID 42)

Lecture Time
09:15 - 09:35
Speakers
  • Kevin J. Harrington (London, United Kingdom)
Session Name
DNA damage response modification as a therapeutic strategy in head and neck cancer
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
DNA damage response modification as a therapeutic strategy in head and neck cancer Special symposium

Conclusions and perspectives (ID 43)

Lecture Time
09:55 - 10:00
Speakers
  • Amanda Psyrri (Athens, Greece)
Session Name
DNA damage response modification as a therapeutic strategy in head and neck cancer
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
08:30 - 10:00
DNA repair: From basic science to the clinic and back Educational session

DNA repair enzymes as anti-cancer drug targets (ID 44)

Lecture Time
10:40 - 11:05
Speakers
  • Thanos Halazonetis (Geneva, Switzerland)
Session Name
DNA repair: From basic science to the clinic and back
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
10:15 - 11:45
DNA repair: From basic science to the clinic and back Educational session

MTHFD2 as a target in leukemia (ID 45)

Lecture Time
11:05 - 11:30
Speakers
  • Thomas Helleday (Stockholm, Sweden)
Session Name
DNA repair: From basic science to the clinic and back
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
10:15 - 11:45
DNA repair: From basic science to the clinic and back Educational session

Mechanisms of DNA-protein crosslink repair in cancer development and therapy (ID 46)

Lecture Time
10:15 - 10:40
Speakers
  • Ivan Dikic (Frankfurt, Germany)
Session Name
DNA repair: From basic science to the clinic and back
Location
Pamplona Auditorium (Hall 2), Fira Gran Via, Barcelona, Spain
Date
29.09.2019
Time
10:15 - 11:45
Drug interaction and the key role of kidney function in onco-haematology Challenge your expert

Presentation by expert (ID 47)

Lecture Time
10:30 - 10:40
Speakers
  • Vincent Launay-Vacher (Paris, CEDEX 13, France)
Session Name
Drug interaction and the key role of kidney function in onco-haematology
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:30 - 11:30
Drug interaction and the key role of kidney function in onco-haematology Challenge your expert

Discussion led by Chair (ID 48)

Lecture Time
10:40 - 11:30
Speakers
  • Ben Sprangers (Leuven, Belgium)
Session Name
Drug interaction and the key role of kidney function in onco-haematology
Location
Salamanca Auditorium (Hall 3), Fira Gran Via, Barcelona, Spain
Date
30.09.2019
Time
10:30 - 11:30